ⓘ Parsatuzumab

                                     

ⓘ Parsatuzumab

Parsatuzumab is a humanized monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to EGFL7.

This drug developed by Genentech / Roche.

                                     
  • Panobacumab mab human Pseudomonas aeruginosa Pseudomonas aeruginosa infection Parsatuzumab mab human EGFL7 cancer Pascolizumab mab humanized IL - 4 asthma Pasotuxizumab